USD
+$0.00
(+0.00%
)At Close (As of Sep 5, 2025)
$11.23M
Market Cap
-
P/E Ratio
-0.3
EPS
$5.50
52 Week High
$0.77
52 Week Low
HEALTHCARE
Sector
Field | Value (AUD) |
---|---|
Gross Profit | $0 |
Total Revenue | $0 |
Cost Of Revenue | $0 |
Costof Goods And Services Sold | $0 |
Operating Income | -$2.9M |
Selling General And Administrative | $1.2M |
Research And Development | $276K |
Operating Expenses | $2.9M |
Investment Income Net | - |
Net Interest Income | -$600K |
Interest Income | - |
Interest Expense | $585K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.2M |
Income Before Tax | -$3.5M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$3.5M |
Comprehensive Income Net Of Tax | - |
Ebit | -$3M |
Ebitda | -$1.7M |
Net Income | -$3.5M |
Field | Value (AUD) |
---|---|
Total Assets | $21M |
Total Current Assets | $303K |
Cash And Cash Equivalents At Carrying Value | $25K |
Cash And Short Term Investments | $25K |
Inventory | $0 |
Current Net Receivables | $183K |
Total Non Current Assets | $20M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $20M |
Intangible Assets Excluding Goodwill | $20M |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $96K |
Other Non Current Assets | - |
Total Liabilities | $5.6M |
Total Current Liabilities | $3.9M |
Current Accounts Payable | $387K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $2.1M |
Total Non Current Liabilities | $1.8M |
Capital Lease Obligations | $0 |
Long Term Debt | $1.8M |
Current Long Term Debt | $2.1M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $3.8M |
Other Current Liabilities | $922K |
Other Non Current Liabilities | - |
Total Shareholder Equity | $15M |
Treasury Stock | - |
Retained Earnings | -$11M |
Common Stock | $27M |
Common Stock Shares Outstanding | $9.4M |
Field | Value (AUD) |
---|---|
Gross Profit | $0 |
Total Revenue | $0 |
Cost Of Revenue | $0 |
Costof Goods And Services Sold | $0 |
Operating Income | -$2.9M |
Selling General And Administrative | $1.2M |
Research And Development | $276K |
Operating Expenses | $2.9M |
Investment Income Net | - |
Net Interest Income | -$600K |
Interest Income | - |
Interest Expense | $585K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.2M |
Income Before Tax | -$3.5M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$3.5M |
Comprehensive Income Net Of Tax | - |
Ebit | -$3M |
Ebitda | -$1.7M |
Net Income | -$3.5M |
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. The company is headquartered in Caulfield, Australia.